What is NAPIGEN?
Founded in 2016 by a distinguished team of industry veterans and academic experts, including Dr. Hajime Sakai and Dr. Jay Keasling, NAPIGEN operates at the intersection of advanced biology and agricultural innovation. The company specializes in developing transformative genetic solutions designed to improve crop yields and sustainability. By focusing on the fundamental mechanisms of plant biology, NAPIGEN provides a unique value proposition to the agrifoodtech sector, aiming to mitigate the impacts of climate change on global food production systems. Its market position is bolstered by a strong intellectual foundation and a strategic network of partners committed to long-term environmental and economic sustainability.
How much funding has NAPIGEN raised?
NAPIGEN has raised a total of $7.9M across 2 funding rounds:
Debt
$72K
Angel/Seed
$7.8M
Debt (2021): $72K with participation from PPP
Angel/Seed (2022): $7.9M led by The Grantham Foundation, Breakout Labs, RA Capital Management, and SVG Partners
Key Investors in NAPIGEN
The Grantham Foundation
A private foundation dedicated to addressing climate change by promoting sustainable technologies and advocating for a transition to renewable energy sources.
Breakout Labs
An investment firm focused on early-stage companies developing research-based solutions in biology, chemistry, and technology to enhance human health and sustainability.
SVG Partners
A venture and innovation platform that accelerates agrifoodtech startups by collaborating with corporations and growers to advance sustainable agricultural practices.
What's next for NAPIGEN?
Looking ahead, NAPIGEN is poised to leverage its recent capital influx to transition its laboratory-proven technologies into scalable, field-ready applications. The strategic focus will likely center on expanding its R&D capabilities and accelerating the commercialization of its genetic platforms. As the company moves deeper into its enterprise-level lifecycle, it will continue to prioritize partnerships with global agricultural stakeholders to integrate its solutions into existing supply chains. The ongoing support from high-profile investors suggests a clear path toward market leadership in the agrifoodtech space, with a continued emphasis on evidence-based innovation and sustainable growth.
See full NAPIGEN company page
